A Study Of The Contraceptive Efficacy, Safety And Tolerability Of The Ag200-15 Transdermal Contraceptive Delivery System (Birth Control Patch).
Posted Date: May 15, 2019
- Investigator: Michael Thomas
- Type of Study: Drug
This study is enrolling healthy females at least 18 years old with regular menstrual cycles who are seeking a birth control method for a year. The investigational birth control patch contains LNG (levonorgestrel) and EE (ethinyl estradiol), which are active ingredients in some Food and Drug Administ
Criteria:
This Study Is Enrolling Healthy Females At Least 18 Years Old With Regular Menstrual Cycles Who Are
Keywords:
Women, Contraceptive, Pregnancy, Ob/Gyn, Birth Control
For More Information:
Jennifer Golan
(513) 584-4100
jennifer.golan@uc.edu